Cargando…

Willingness to receive future COVID-19 vaccines following the COVID-19 epidemic in Shanghai, China

BACKGROUND: There are no pharmacological interventions currently available to prevent the transmission of SARS-CoV-2 or to treat COVID-19. The development of vaccines against COVID-19 is essential to contain the pandemic. we conducted a cross-sectional survey of Shanghai residents to understand resi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Yehong, Zhang, Junjie, Wu, Wenwen, Liang, Man, Wu, Qiang-Song
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8188944/
https://www.ncbi.nlm.nih.gov/pubmed/34107930
http://dx.doi.org/10.1186/s12889-021-11174-0
_version_ 1783705423108374528
author Zhou, Yehong
Zhang, Junjie
Wu, Wenwen
Liang, Man
Wu, Qiang-Song
author_facet Zhou, Yehong
Zhang, Junjie
Wu, Wenwen
Liang, Man
Wu, Qiang-Song
author_sort Zhou, Yehong
collection PubMed
description BACKGROUND: There are no pharmacological interventions currently available to prevent the transmission of SARS-CoV-2 or to treat COVID-19. The development of vaccines against COVID-19 is essential to contain the pandemic. we conducted a cross-sectional survey of Shanghai residents to understand residents’ willingness to be vaccinated with any future COVID-19 vaccines and take measures to further improve vaccination coverage. METHODS: We conducted a cross-sectional survey using self-administered anonymous questionnaires from 1 July to 8 September 2020. The main outcome was willingness of participants, and any children or older individuals living with them, to receive future COVID-19 vaccines. Logistic regression analyses were used to explore potential factors associated with vaccination willingness. RESULTS: A total of 1071 participants were asked about their willingness to receive future COVID-19 vaccines, for themselves and at least 747 children and 375 older individuals (≥60 years old) living with them. The highest proportion of expected willingness to vaccinate was among participants (88.6%), followed by children (85.3%) and older individuals (84.0%). The main reasons for reluctance to vaccinate among 119 participants were doubts regarding vaccine safety (60.0%) and efficacy (28.8%). Participants with a self-reported history of influenza vaccination were more likely to accept COVID-19 vaccines for themselves [adjusted odds ratio (OR) = 1.83; 95% confidence interval (CI): 1.19–2.82], their children (adjusted OR = 2.08; 95%CI: 1.30–3.33), and older individuals in their household (adjusted OR = 2.12; 95%CI: 1.14–3.99). Participants with older individuals in their families were less willing to vaccinate themselves (adjusted OR = 0.59; 95%CI: 0.40–0.87) and their children (adjusted OR = 0.58; 95%CI: 0.38–0.89). CONCLUSIONS: Participants were more reluctant to accept COVID-19 vaccines for older individuals living with them. The presence of older individuals in the home also affected willingness of participants and their children to be vaccinated.
format Online
Article
Text
id pubmed-8188944
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-81889442021-06-10 Willingness to receive future COVID-19 vaccines following the COVID-19 epidemic in Shanghai, China Zhou, Yehong Zhang, Junjie Wu, Wenwen Liang, Man Wu, Qiang-Song BMC Public Health Research BACKGROUND: There are no pharmacological interventions currently available to prevent the transmission of SARS-CoV-2 or to treat COVID-19. The development of vaccines against COVID-19 is essential to contain the pandemic. we conducted a cross-sectional survey of Shanghai residents to understand residents’ willingness to be vaccinated with any future COVID-19 vaccines and take measures to further improve vaccination coverage. METHODS: We conducted a cross-sectional survey using self-administered anonymous questionnaires from 1 July to 8 September 2020. The main outcome was willingness of participants, and any children or older individuals living with them, to receive future COVID-19 vaccines. Logistic regression analyses were used to explore potential factors associated with vaccination willingness. RESULTS: A total of 1071 participants were asked about their willingness to receive future COVID-19 vaccines, for themselves and at least 747 children and 375 older individuals (≥60 years old) living with them. The highest proportion of expected willingness to vaccinate was among participants (88.6%), followed by children (85.3%) and older individuals (84.0%). The main reasons for reluctance to vaccinate among 119 participants were doubts regarding vaccine safety (60.0%) and efficacy (28.8%). Participants with a self-reported history of influenza vaccination were more likely to accept COVID-19 vaccines for themselves [adjusted odds ratio (OR) = 1.83; 95% confidence interval (CI): 1.19–2.82], their children (adjusted OR = 2.08; 95%CI: 1.30–3.33), and older individuals in their household (adjusted OR = 2.12; 95%CI: 1.14–3.99). Participants with older individuals in their families were less willing to vaccinate themselves (adjusted OR = 0.59; 95%CI: 0.40–0.87) and their children (adjusted OR = 0.58; 95%CI: 0.38–0.89). CONCLUSIONS: Participants were more reluctant to accept COVID-19 vaccines for older individuals living with them. The presence of older individuals in the home also affected willingness of participants and their children to be vaccinated. BioMed Central 2021-06-09 /pmc/articles/PMC8188944/ /pubmed/34107930 http://dx.doi.org/10.1186/s12889-021-11174-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Zhou, Yehong
Zhang, Junjie
Wu, Wenwen
Liang, Man
Wu, Qiang-Song
Willingness to receive future COVID-19 vaccines following the COVID-19 epidemic in Shanghai, China
title Willingness to receive future COVID-19 vaccines following the COVID-19 epidemic in Shanghai, China
title_full Willingness to receive future COVID-19 vaccines following the COVID-19 epidemic in Shanghai, China
title_fullStr Willingness to receive future COVID-19 vaccines following the COVID-19 epidemic in Shanghai, China
title_full_unstemmed Willingness to receive future COVID-19 vaccines following the COVID-19 epidemic in Shanghai, China
title_short Willingness to receive future COVID-19 vaccines following the COVID-19 epidemic in Shanghai, China
title_sort willingness to receive future covid-19 vaccines following the covid-19 epidemic in shanghai, china
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8188944/
https://www.ncbi.nlm.nih.gov/pubmed/34107930
http://dx.doi.org/10.1186/s12889-021-11174-0
work_keys_str_mv AT zhouyehong willingnesstoreceivefuturecovid19vaccinesfollowingthecovid19epidemicinshanghaichina
AT zhangjunjie willingnesstoreceivefuturecovid19vaccinesfollowingthecovid19epidemicinshanghaichina
AT wuwenwen willingnesstoreceivefuturecovid19vaccinesfollowingthecovid19epidemicinshanghaichina
AT liangman willingnesstoreceivefuturecovid19vaccinesfollowingthecovid19epidemicinshanghaichina
AT wuqiangsong willingnesstoreceivefuturecovid19vaccinesfollowingthecovid19epidemicinshanghaichina